Jobs / United States / Glaxosmithkline LLC
Director, Disease Area Lead, Oncology (Haem)
Glaxosmithkline LLC · 🇺🇸 3 Locations
Sponsorship verdict
Sponsorship possible
One solid signal, not two — worth applying, and worth asking about sponsorship early.
- Employer is on a government sponsor recordThe US Department of Labor certified 39 H-1B/E-3 labor condition applications for this employer between Oct 2025 and Jun 2026 (latest Jun 2026) — the step every H-1B hire needs first. USCIS also records 15 H-1B approvals in FY2023. Source: LCA disclosure data (US Department of Labor (OFLC)).
- The posting doesn’t mention sponsorshipSilence isn’t a refusal — ask the recruiter before investing much time.
- No salary bar for this routeH-1B has no fixed salary bar: the employer must pay at least the prevailing wage for the role and area. Cap-subject employers enter a lottery weighted by wage level. Source: https://www.federalregister.gov/documents/2025/12/29/2025-23853/weighted-selection-process-for-registrants-and-petitioners-seeking-to-file-cap-subject-h-1b, rules effective 2026-02-27.
- What Glaxosmithkline LLC paid sponsored hires in similar roles1 certified filing for “Associate Director - Global Regulatory Affairs, Oncology” (Regulatory Affairs Managers) in WA: $154k–$154k, median $154k. Most were filed at wage level II (100%) — 2 lottery entries, ≈31% projected selection odds for cap-subject employers. Source: US Department of Labor LCA disclosure data (Oct 2025 – Jun 2026).
- Confirmed live todayWhen a source last listed this job as open.
US H-1B: cap-subject employers enter a lottery weighted by wage level — Level I gets 1 entry, Level IV gets 4 (DHS projected selection odds ≈15% at Level I to ≈61% at Level IV). Universities and non-profit research employers are cap-exempt. The $100,000 fee for new petitions from abroad is currently blocked by a court order (appeal pending).
A verdict summarises public evidence; it is not legal advice and never a guarantee — the employer and the immigration authority decide. Sign in to factor in where you can already work.
Or apply yourself on the official page →
Sponsor Radar — Glaxosmithkline LLC
The US Department of Labor certified 39 H-1B/E-3 labor condition applications for this employer between Oct 2025 and Jun 2026 (latest Jun 2026) — the step every H-1B hire needs first. USCIS also records 15 H-1B approvals in FY2023. Source: LCA disclosure data (US Department of Labor (OFLC)).
Past sponsorship or register membership never guarantees sponsorship for this vacancy or for you. Full Sponsor Radar for Glaxosmithkline LLC →
About the role
Senior Director Clinical Operations Disease Area Lead Oncology Are you ready to lead and manage a team of senior experts in a role that drives innovation and transforms healthcare on a global scale? At GSK, we are looking for a visionary leader to join us as a Disease Area Lead. This is an opportunity to shape the future of clinical operations, accelerate development timelines, and make a meaningful impact on health outcomes worldwide. If you thrive in a dynamic, collaborative environment and are passionate about delivering excellence, this Oncology, Senior Director Disease Area Lead role is an exciting move to explore. Job Purpose As the Oncology Senior Director Disease Area Lead at GSK, you will play a pivotal role in driving the global strategy for clinical operations within your assigned portfolio. You will ensure operational excellence, accelerate development timelines, and optimize delivery to support GSK’s mission of improving health outcomes worldwide. Key Responsibilities • Lead a high-performing global team of Clinical Operations Asset Leads (COALs) and Associate COALs setting the strategic vision and operational direction for delivering the disease area portfolio including Early Phase strategy and delivery for the Disease Area. • Contribute to the Business Development strategic input when business development opportunities are evaluated by providing strategic leadership, conducting due diligence, building of a clinical development plan in preparation for governance. • Lead the Disease Area Matrix Leadership Team by partnering with key Oncology stakeholders to shape the vision and resourcing/delivery strategy to support the clinical portfolio from design through regulatory submission/approvals. • Provide leadership and coaching to team members who are accountable for the delivery of clinical development programs, ensuring the development and retention of top talent. Foster a culture of innovation, accountability, and high performing team enabling the team to work effectively with the key cross-functional leadership teams and project team. • Work with GCO TA head to set the strategic direction for the GCO TA teams, ensuring alignment with GSK's R&D objectives and overall company strategy. • Identify and integrate best practices across the organization, ensuring their effective implementation to enhance business processes, optimize operational efficiency and foster continuous improvement. • Act as the single point of accountability for all operational aspects of Oncology, providing strategic oversight and ensuring delivery against key milestones, timelines and quality standards. • Embed innovative approaches to drive delivery optimization and to accelerate development timelines across the life cycle of an asset. • Proactively identify and manage risks associated with clinical program delivery. Develop and implement strategies to mitigate risks and ensure the successful execution of clinical trials. • Shape and sustain a culture of excellence, collaboration, accountability and innovation within the organization. Foster the sharing of best practices, the development of key talent, and the creation of a community focused on delivering results in a fast-evolving and competitive environment. Basic Qualifications • Bachelor’s degree in Life Sciences • Extensive experience of clinical trial management of phase II-III oncology studies • Significant experience leading a portfolio of oncology trials or asset lead in a clinical operations setting • Proven line and matrix leadership and ability to navigate, lead and influence within a complex matrix environment. • Experience collaborating with external stakeholders, including CROs, academia, and patient networks Preferred Qualifications • Advanced degree (Master’